Thushyanthan Pathmalingam

Thushyanthan Pathmalingam practices at Canton-Potsdam Hospital in Potsdam, New York, part of Rochester Regional Health.

Thushyanthan Pathmalingam's NPI, 1104278555, was assigned on July 11, 2016. Thushyanthan Pathmalingam graduated from University of Medicine & Health Sciences St. Kitts in 2015. Thushyanthan Pathmalingam holds New York license 300572.

Thushyanthan Pathmalingam's primary practice is Canton-Potsdam Hospital, at 50 Leroy Street, Potsdam, NY 13676 in St. Lawrence County. The practice phone is (315) 265-3300.

Thushyanthan Pathmalingam's primary practice is Canton-Potsdam Hospital in Potsdam, New York, part of Rochester Regional Health. Thushyanthan Pathmalingam is also affiliated with Massena Hospital. The medical group on file is Canton-Potsdam Hospital. Dmand AI also links Thushyanthan Pathmalingam to 1 more home health agency, named with a free account. Thushyanthan Pathmalingam's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Thushyanthan Pathmalingam practices, 3 sites in all. Vendor and product names are available with a free account.

Family medicine is Thushyanthan Pathmalingam's primary specialty in the NPI Registry, under taxonomy code 207Q00000X. Dmand AI has Thushyanthan Pathmalingam's licenses on file in 2 states: New York and Pennsylvania.

CMS data shows 466 Medicare services from Thushyanthan Pathmalingam across 4 procedure codes in 2024, for 123 Medicare patients. Medicare paid $28,050 for them. Every service was in an office.

CMS counts 123 Medicare patients who saw Thushyanthan Pathmalingam in 2024. The largest group is 65 to 74, with 57 patients. 72% of them have high blood pressure, and 63% have high cholesterol. 19% are also on Medicaid. Their average risk score is 1.15, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Thushyanthan Pathmalingam's median patient age at 60, with 26% women.

In 2024, Thushyanthan Pathmalingam wrote 4,824 Medicare Part D claims for 296 patients. 84% of them were for generic drugs. CMS names the drug for 4,258 of them, across 80 drugs with 11 or more claims each, at $487,058 in total drug cost. In 2023, CMS named 3,326 claims across 73 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 99 out of 100 for Thushyanthan Pathmalingam for performance year 2024, reported through an alternative payment model (APM). Thushyanthan Pathmalingam accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 108 general payments to Thushyanthan Pathmalingam from 19 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. AstraZeneca Pharmaceuticals LP paid the most, $690.

Thushyanthan Pathmalingam graduated from University of Medicine & Health Sciences St. Kitts in 2015.